Press release
Peptide Therapeutics Global Market Report 2025: Surge amidst Rising Chronic Diseases and Technological Advancements
Peptide Therapeutics Market Size
What Is The Projected Market Size Of The Global Peptide Therapeutics Global Market Report 2025 And Its Growth Rate?
The peptide therapeutics global market witnessed a significant upward trajectory, emphasizing progress in personalised medicine and rare disease treatments, among other factors. Here's a glance at some crucial numbers:
• The market size catapulted from $45.15 billion in 2024 to $49.67 billion in 2025, marking a compound annual growth rate (CAGR) of 10.0%.
• It is expected to expand further to $76.64 billion by 2029 at a CAGR of 11.5%.
What Is Driving The Growth In The Peptide Therapeutics Global Market Report 2025?
The unprecedented growth in the prevalence of chronic diseases has emerged as a major driver for the peptide therapeutics market's expansion. Chronic diseases, which are persistent, are often incurable but can be managed, and their prevalence has increased due to factors like poor nutrition, alcohol usage, physical inactivity, and usage of tobacco products, among others. Peptide therapeutics serve as a critical component in the prevention and treatment of certain chronic diseases.
Request A Free Sample Copy:https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp
Who Are the Key Players Driving Peptide Therapeutics Global Market Report 2025 Growth?
The major players propelling the growth of the peptide therapeutics market include
• Pfizer Inc.
• Jhonson & Jhonson
• Abbvie Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Sanofi SA
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk AS
• Teva Pharmaceuticals Industries Ltd.
• Bachem Holding AG
• PolyPeptide Laboratories BV
• Arcus Biosciences Inc.
• Pepscan Therapeutics
• Peptech Inc.
• Peptide Logic Inc.
• SELLAS Life Sciences Group
• Ever Neuro Pharma GmbH
• Zealand Pharma AG
• PepGen Inc.
• Pepticom S.A.
• Peptide Technologies Corporation
• SynPeptide Inc.
• Peptimmune Inc.
• Merck & Co Inc.
What Are The Key Trends In The Peptide Therapeutics Global Market Report 2025?
Key trends to watch include:
• Technological advancements in peptide synthesis
• Growing investments and funding
• Emphasis on peptide drug safety
• Market expansion in emerging economies
• Integration of artificial intelligence
What Are The Segments Of The Global Peptide Therapeutics Global Market Report 2025?
The peptide therapeutics market is categorised by:
1) Type: Generic, Branded
2) Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
Which Region Leads The Peptide Therapeutics Global Market Report 2025?
In 2024, North America emerged as the leading region in the peptide therapeutics market. However, the Asia-Pacific is expected to witness the fastest growth in the forecast period.
Pre-book the Report for Swift Delivery:https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
What Is Covered In The Peptide Therapeutics Global Market Report 2025 Global Market Report?
- Market Size Analysis: Analyze the Peptide Therapeutics Global Market Report 2025 size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Peptide Therapeutics Global Market Report 2025 for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Peptide Therapeutics Global Market Report 2025 growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Peptide Therapeutics Global Market Report 2025.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Global Market Report 2025: Surge amidst Rising Chronic Diseases and Technological Advancements here
News-ID: 3845047 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
